European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1

The first issue of the European Pharmaceutical Review (EPR) for 2025 features a range of articles focusing on key topics within the pharmaceutical industry. The publication covers advancements in manufacturing processes, innovations in drug delivery systems, developments in process analytical technology (PAT), and the growing field of RNA therapeutics.

The issue provides insights into current trends shaping pharmaceutical research and production. Articles delve into how PAT is being utilized to enhance efficiency and quality control during manufacturing. Additionally, the publication explores emerging techniques in drug delivery aimed at improving therapeutic outcomes. A significant portion of the issue is dedicated to RNA therapeutics, reflecting its increasing prominence as a platform for developing treatments for various diseases. Other topics are also included to provide a comprehensive overview of ongoing developments in the sector.

Date: March, 2025

Newsflash | Powered by GeneOnline AI

Related posts:

Researchers Achieve High Throughput in Nanomaterial Development for Drug Delivery Imaging Discovery Promises Faster Drug Development Breakthrough in Sustainable Chemistry: Waste Converted into Pharmaceuticals Using Artificial Photosynthesis U.K. Government Proposes Increased Drug Rebates to Support NHS, Faces Industry Pushback

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後